Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > OK Providers > Internists & Internal Medicine Doctors

Dr. Mohamad Osama Khawandanah, MD

Accepting New Patients

(15 Ratings)

Specializes in: Internal Medicine (Adult Medicine) and Hematology (Blood Disorders)

University of Jordan Faculty of Medicine

Professional interests include: lymphoma, bone marrow transplant, hemolytic anemia, and more.

Oklahoma City, OK 73104

1-800-NE1-0thS

Dr. Mohamad Osama Khawandanah, MD is an internist in Oklahoma City, OK specializing in internal medicine (adult medicine) and hematology (blood disorders). He graduated from University of Jordan Faculty of Medicine. Dr. Mohamad Osama Khawandanah, MD is affiliated with OU Health and OU HEALTH PARTNERS INC.

Office Locations

Address:

800 Northeast 10th Street
Oklahoma City, OK 73104

Address:

591 E 36th Street N
Tulsa, OK 74106

Address:

Oklahoma City, OK 73104

Some issues Dr. Mohamad Osama Khawandanah, MD can help you with:

Platelet Disorders

Platelet disorders are conditions caused by abnormally low or high levels of platelets in the blood, or by platelets that do not function correctly. Platelets are small blood cells that help stop bleeding by clumping together and forming blood clots, allowing the body to heal.

Thrombocytopenia is a disorder where people have too few platelets. With too few platelets in the bloodstream, the blood is unable to properly clot. People with thrombocytopenia may experience prolonged external and internal bleeding. Large purple bruises (ecchymoses) and small red skin spots (petechiae) in the skin and mouth are common in those with thrombocytopenia. Other symptoms of the disorder include bleeding gums, blood in bodily fluids, and fatigue. Thrombocytopenia most often arises from a different condition or treatment, such as alcoholism, autoimmune disease, cancer treatments, viruses (such as Hepatitis C and HIV), bone marrow diseases (such as leukemia and aplastic anemia), enlarged spleen, and exposure to toxic chemicals. In rare cases, thrombocytopenia is inherited.

Thrombocytosis is a disorder where people have too high of a concentration of platelets. Excess platelets can cause blood to clot in the veins. Blood clots in the veins are particularly dangerous, as they can obstruct blood flow and cause heart attacks and strokes. Thrombocytosis has two forms:

Thrombocythemia, also referred to as primary or essential thrombosis (ET), develops from irregular bone marrow cells that produce too many platelets. The cause of these bone marrow cells is unknown.
Reactive thrombosis (RT), also referred to as secondary thrombosis, arises from a different condition such as cancer, anemia, spleen removal, or infection. It is most common in older adults, but can occur in people of all ages. Symptoms of reactive thrombosis may gradually develop over time and typically include bruising, gum bleeding, and blood clotting.
Dysfunctional platelets are unable to perform the clotting function in the blood. People with dysfunctional platelets may have normal or low platelet counts. Causes of dysfunctional platelets include autoimmune disorders, hemolysis, infections, blood and bone marrow problems, and liver or kidney conditions.

If a doctor suspects a patient has a platelet disorder, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Platelet disorders can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights. Tests measuring prothrombin time (PT), or how long it takes for blood to clot, can also detect dysfunctional platelets. If platelets do not coagulate within a certain time frame, the patient most likely has dysfunctional platelets.

Treatments for low platelet counts include steroids like Prednisone, that can assist with platelet production. If a patient's low platelet count is caused by spleen problems, spleen removal (splenectomy) may be recommended. To treat the prolonged bleeding caused by thrombocytopenia, doctors frequently prescribe Dempressin, a hormone that promotes blood clotting. Antifibrinolytic medications such as tranexamic acid may also aid in the promotion of clotting and the prevention of bleeding. For patients with severe platelet disorders (either low platelet count and dysfunctional platelets), blood transfusions may be prescribed. Platelet blood transfusions deliver donated platelets to patients intravenously, replenishing the volume of functioning platelets.

Patients with high platelet counts are frequently prescribed a daily dose of over-the-counter medication aspirin. Platelet-lowering medications, such as hydroxyurea and Intron A, may reduce the likelihood of blood clot formation. Excess platelets may also be removed from the blood by a procedure called plateletpheresis or platelet reduction apheresis, where blood is drawn, circulated into a centrifuge that separates the blood components, and returned to the body with some platelets extracted. Plateletpheresis is a rare procedure reserved for patients who have severe clotting.

Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with low blood counts should avoid blood-thinning medications, alcohol, and activities that could lead to injury. Patients with high blood count are advised to drink plenty of water, exercise regularly, and to avoid smoking. Many people with platelet disorders can live healthy and fulfilling lives with proper treatment and precautions.

doctor visit	63

**Gender**
Male	15
Female	25

**Age**
From 65 to 74	22
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	55
High Cholesterol	28
Stroke	0
Ischemic Heart Disease	35
Depression	28
Chronic Kidney Disease	38
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	0
Cancer	0

biological response modifier (BRM) therapy	46
chemotherapy	46
doctor visit	192
hospital care	54
inpatient care	54
minimally invasive procedures	46
port flush	20

**Gender**
Male	176
Female	230

**Ethnicity**
Non-Hispanic White	324
Black	42
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	212
From 75 to 84	0
85 and over	0
Less than 65	132

Hypertension	66
High Cholesterol	36
Stroke	7
Ischemic Heart Disease	33
Depression	33
Chronic Kidney Disease	41
Asthma	10
Osteoperosis	0
Atrial Fibrilation	7
Heart Failure	24
Chronic Obstructive Pulmonary Disease	20
Diabetes	28
Dementia	0
Cancer	33

**Gender**
Male	170
Female	283

**Ethnicity**
Non-Hispanic White	367
Black	45
Hispanic	0
Asian	0
Other	0
Native American	20

**Age**
From 65 to 74	227
From 75 to 84	92
85 and over	14
Less than 65	120

Hypertension	65
High Cholesterol	35
Stroke	4
Ischemic Heart Disease	31
Depression	28
Chronic Kidney Disease	35
Asthma	20
Osteoperosis	7
Atrial Fibrilation	8
Heart Failure	20
Chronic Obstructive Pulmonary Disease	18
Diabetes	28
Dementia	8
Cancer	32

biological response modifier (BRM) therapy	346
chemotherapy	346
doctor visit	171
hospital care	74
inpatient care	74
minimally invasive procedures	364
port flush	31

**Gender**
Male	204
Female	272

**Ethnicity**
Non-Hispanic White	387
Black	45
Hispanic	0
Asian	0
Other	0
Native American	24

**Age**
From 65 to 74	244
From 75 to 84	114
85 and over	21
Less than 65	97

Hypertension	72
High Cholesterol	42
Stroke	5
Ischemic Heart Disease	34
Depression	30
Chronic Kidney Disease	37
Asthma	8
Osteoperosis	7
Atrial Fibrilation	9
Heart Failure	23
Chronic Obstructive Pulmonary Disease	19
Diabetes	34
Dementia	7
Cancer	35

biological response modifier (BRM) therapy	65
chemotherapy	65
doctor visit	259
hospital care	60
inpatient care	60
minimally invasive procedures	65

**Gender**
Male	125
Female	137

**Ethnicity**
Non-Hispanic White	208
Black	27
Hispanic	0
Asian	0
Other	0
Native American	15

**Age**
From 65 to 74	143
From 75 to 84	0
85 and over	0
Less than 65	64

Hypertension	74
High Cholesterol	47
Stroke	6
Ischemic Heart Disease	31
Depression	36
Chronic Kidney Disease	47
Asthma	10
Osteoperosis	5
Atrial Fibrilation	6
Heart Failure	23
Chronic Obstructive Pulmonary Disease	15
Diabetes	34
Dementia	8
Cancer	22

doctor visit	237
hospital care	151
inpatient care	151

**Gender**
Male	82
Female	92

**Ethnicity**
Non-Hispanic White	130
Black	19
Hispanic	0
Asian	0
Other	0
Native American	13

**Age**
From 65 to 74	93
From 75 to 84	0
85 and over	0
Less than 65	46

Hypertension	74
High Cholesterol	53
Stroke	6
Ischemic Heart Disease	33
Depression	36
Chronic Kidney Disease	50
Asthma	10
Osteoperosis	8
Atrial Fibrilation	7
Heart Failure	25
Chronic Obstructive Pulmonary Disease	18
Diabetes	35
Dementia	11
Cancer	11

doctor visit	183
hospital care	220
inpatient care	220

**Gender**
Male	92
Female	77

**Ethnicity**
Non-Hispanic White	134
Black	17
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	97
From 75 to 84	35
85 and over	0
Less than 65	0

Hypertension	70
High Cholesterol	47
Stroke	0
Ischemic Heart Disease	38
Depression	37
Chronic Kidney Disease	50
Asthma	10
Osteoperosis	7
Atrial Fibrilation	8
Heart Failure	22
Chronic Obstructive Pulmonary Disease	17
Diabetes	31
Dementia	12
Cancer	11

doctor visit	528
hospital care	409
inpatient care	409

Average Medicare Procedure Volume From 2014 - 2021

Volume of procedures performed by Dr. Mohamad Osama Khawandanah, MD for Medicare patients.

The highest averages for the top procedures that Dr. Mohamad Osama Khawandanah, MD treated as an internist in Oklahoma City, OK were minimally invasive procedures, chemotherapy, biological response modifier (BRM) therapy and hospital care.

aspiration	11
biological response modifier (BRM) therapy	193
bone marrow tests	22
chemotherapy	193
diagnostic procedures	22
doctor visit	234
hospital care	161
inpatient care	161
minimally invasive procedures	205
preventive care	10
vaccines	10

Average Medicare Patient Data From 2014 - 2021

Information about Medicare patients treated by Dr. Mohamad Osama Khawandanah, MD.

**Gender**
Female	111
Male	86

**Ethnicity**
Black / African American	19
Asian / Pacific Islander	0
Non-Hispanic White	155
Hispanic	0
Native American / Alaskan Native	7
Other	0

**Age**
85 and over	3
75 to 84	24
Less than 65	45
65 to 74	103

Average of Total of Conditions of Medicare patients treated by Dr. Mohamad Osama Khawandanah, MD From 2014 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Mohamad Osama Khawandanah, MD treated were hypertension, chronic kidney disease, high cholesterol and ischemic heart disease.

Hypertension	47
High Cholesterol	28
Stroke	2
Ischemic Heart Disease	23
Depression	22
Chronic Kidney Disease	29
Asthma	6
Osteoporosis	3
Heart Failure	13
Chronic Obstructive Pulmonary Disease	10
Diabetes	19
Atrial Fibrillation	4
Dementia	4
Cancer	14

Education & Training

Dr. Mohamad Osama Khawandanah, MD graduated from University of Jordan Faculty of Medicine. He completed residency at Residency Internal Medicine OU College of Medicine Oklahoma City, OK. He is certified by the American Board of Internal Medicine American Board of Internal Medicine, Hematology AMERICAN BOARD OF INTERNAL MEDICINE, Medical Oncology and has a state license in Oklahoma.

Medical School: University of Jordan Faculty of Medicine

Residency: Residency Internal Medicine OU College of Medicine Oklahoma City, OK (2011)

Board Certification: American Board of Internal Medicine American Board of Internal Medicine, Hematology AMERICAN BOARD OF INTERNAL MEDICINE, Medical Oncology

Licensed In: Oklahoma

Affiliations & Hospitals

Dr. Mohamad Osama Khawandanah, MD is associated with these hospitals and organizations:

OU Health

OU HEALTH PARTNERS INC

Ratings & Reviews

Dr. Mohamad Osama Khawandanah, MD has an exceptional overall rating with an average of 4.7 out of 5 stars based on 15 ratings. We collect ratings and reviews of Dr. Mohamad Osama Khawandanah, MD from all over the web to help you find the right in Oklahoma City, OK.

4.7

Overall Rating

(15 Ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Mohamad Osama Khawandanah, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Novartis Pharmaceuticals Corporation	$218 KYMRIAH $126	JADENU $92
AstraZeneca Pharmaceuticals LP	$153 CALQUENCE $153
Jazz Pharmaceuticals Inc.	$133 Defitelio $133
E.R. Squibb & Sons, L.L.C.	$124 EMPLICITI $124
Seattle Genetics, Inc.	$118 ADCETRIS $118
Other	$460 ELIQUIS $111	JAKAFI $75	Empaveli $53	Gazyva $45	XARELTO $20	Other $156

**Types of Payments**
Food and Beverage	$1,078
Education	$128

Research Payments

Dr. Mohamad Osama Khawandanah, MD has received 2 research payments totaling $3,885.

Biography

Dr. Mohamad Khawandanah sees patients in Oklahoma City, OK and Tulsa, OK. His medical specialty is hematology (blood disorders). Areas of expertise for Dr. Khawandanah include platelet disorders, acute leukemia, and hemolytic anemia. He is professionally affiliated with OU Health. Dr. Khawandanah is a graduate of the University of Jordan Faculty of Medicine. Patient reviews placed him at an average of 4.5 stars (out of 5). Dr. Khawandanah's practice in Oklahoma City, OK is open to new patients as reported by Doctor.com.

Select Year:

Dr. Mohamad Osama Khawandanah, MD

Office Locations

Some issues Dr. Mohamad Osama Khawandanah, MD can help you with:

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

2014 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Mohamad Osama Khawandanah, MD in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Mohamad Osama Khawandanah, MD in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Mohamad Osama Khawandanah, MD in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Mohamad Osama Khawandanah, MD in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Mohamad Osama Khawandanah, MD in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Mohamad Osama Khawandanah, MD in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Mohamad Osama Khawandanah, MD in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

Average Medicare Procedure Volume From 2014 - 2021

Average Medicare Patient Data From 2014 - 2021

Average of Total of Conditions of Medicare patients treated by Dr. Mohamad Osama Khawandanah, MD From 2014 - 2021

Education & Training

Affiliations & Hospitals

Ratings & Reviews

General Payments

Research Payments

Biography

Internists & Internal Medicine Doctors in Nearby Locations

Other Providers in Oklahoma City, OK